Mode
Text Size
Log in / Sign up
N/A Completed N=60 Randomized Treatment

Project EQuIP: Empowering Queer Identities in Psychotherapy

Sexual Minority Stress
Source: ClinicalTrials.gov NCT03721276 ↗
Enrolled (actual)
60
Serious AEs
1.1%
Results posted
Oct 2021
Primary outcomePrimary: Depression — 27.57; 29.70; 26.86; 20.44 score on a scale

Summary

The aim of this study is to develop an evidence-based psychosocial intervention for sexual minority women. This intervention will specifically target the adverse mental and behavioral health outcomes disproportionately experienced by sexual minority women, including depression, suicidality, and alcohol abuse, which are known to be driven by stigma-related stressors associated with their sexual orientation (i.e., minority stress processes).

Outcome Measures

OutcomeResultp-value
PRIMARY
Depression
27.57; 29.70; 26.86; 20.44; 24.83; 19.00
PRIMARY
Brief Symptom Inventory
1.80; 1.74; 1.85; 1.38; 1.64; 1.16
PRIMARY
Alcohol Use
3.93; 3.63; 3.34; 2.16; 2.80; 1.92
SECONDARY
Overall Depression Severity and Impairment Scale
6.17; 6.30; 7.69; 4.09; 5.85; 3.88
SECONDARY
Overall Anxiety Severity and Impairment Scale
8.20; 8.80; 8.03; 6.00; 6.08; 6.17
SECONDARY
Suicidal Ideation Attributes Scale
5.03; 4.13; 5.59; 2.09; 2.73; 1.46
SECONDARY
Lesbian, Gay, and Bisexual Identity Scale-Internalized Homonegativity Subscale
1.49; 1.72; 1.32; 1.63; 1.36; 1.49

Eligibility Criteria

For Phase 3

Inclusion Criteria

  • sexual minority status operationalized as identity (e.g., lesbian, bisexual, pansexual, queer)
  • aged 18-35
  • self-identification as a woman with the option of selecting multiple gender identities
  • symptoms of anxiety or depression within the past 90 days (≥ 2.5 on the BSI-4 for either anxiety or depression)
  • at least one instance of past-90-day heavy drinking (i.e., ≥ 4 drinks in one sitting)
  • 6-month NYC residential stability and availability
  • English fluency

Exclusion Criteria

  • active psychosis or active mania
  • active suicidality or active homicidality
  • currently in mental health treatment exceeding one day per month
  • having received any cognitive-behavioral therapy treatment in the past 12 months
  • evidence of gross cognitive impairment
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03721276). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search